Stock listing
Chimeric Therapeutics Limited Temp
Selected listing: CHMDA · ASX · AUD · AU
Chimeric Therapeutics Limited Temp (ASX:CHMDA). Latest release Apr 29, 2026: Quarterly Activities/Appendix 4C Cash Flow Report.
- Ticker
- ASX:CHMDA
- Asset type
- Stock
- Exchange
- ASX
- Currency
- AUD
About Chimeric Therapeutics Limited Temp
Chimeric Therapeutics Limited (ASX: CHMDA) is a public biotechnology company based in Australia, focused on developing innovative cell therapies for cancer treatment. The company aims to advance its proprietary technology to improve patient outcomes in oncology. Chimeric Therapeutics is committed to addressing unmet medical needs through its research and development efforts in the field of cell-based therapies.
Latest news from Chimeric Therapeutics Limited Temp
Research Chimeric Therapeutics Limited Temp
Chimeric Therapeutics Limited Temp company profile
View the public company page for Chimeric Therapeutics Limited Temp on 6ix.
Chimeric Therapeutics Limited Temp news
Read company news and market updates connected to Chimeric Therapeutics Limited Temp.
Chimeric Therapeutics Limited Temp investor events
Find investor webinars, events, and replay context for Chimeric Therapeutics Limited Temp.